Fig. 3

ROC curves for evaluating the predictive efficacy of pentraxin-3 and conventional laboratory parameters. Figure shows the predictive efficacy of pentraxin-3, AST, PLT, WBC, and ALB for the prognosis (death) in patients with HFRS. Pentraxin-3 showed significant predictive value, with the AUC of 0.753 (P = 0.003). Abbreviations: ROC curve, Receiver operating characteristic curve; AUC, Area under the ROC curve; WBC, White blood cells; PLT, Platelet; AST, Aspartate aminotransferase; ALB, Albumin